Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) (2009)
Authors: Benjamin D. Smith, MD, Douglas W. Arthur, MD, Thomas A. Buchholz, MD, Bruce G. Haffty, MD, Carol A. Hahn, MD, Patricia H. Hardenbergh, MD, Thomas B. Julian, MD, Lawrence B. Marks, MD, Dorin A. Todor, PhD, Frank A. Vicini, MD, Timothy J. Whelan, MD, Julia White, MD, Jennifer Y. Wo, MD, and Jay R. Harris, MD
This consensus statement provides guidance for patients and physicians regarding the use of accelerated partial breast irradiation (APBI), based on current published evidence complemented by expert opinion. It investigates the literature regarding which patients may be considered for APBI outside of a clinical trial; proper informed consent for patients treated with APBI outside of a clinical trial; diagnostic imaging tests needed for patients treated with APBI; integration of multidisciplinary care with surgery and medical oncology; comparison of various techniques for APBI based on clinical and dosimetric data; and minimum requirements for APBI treatment planning and dosimetry. Accelerated partial breast irradiation provides faster, more convenient treatment after breast conserving surgery. It may demonstrate long-term effectiveness and safety comparable to that of whole breast irradiation (WBI) for selected patients with early breast cancer.
Read the consensus statement.